Moreover, in another study, five LM+ patients were analyzed by single-cell RNA sequencing, which showed that tumor cells (in the CSF) expressed the iron-binding protein lipocalin-2 (LCN2) and its receptor SCL22A17 [64]. This evidence concerns the gene LCN2 and neoplasm.